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Background
Fenugreek (Trigonella foenum-graecum L.) is widely
used in Indian-style spiced foods. Some cases of allergic
reactions to fenugreek have been reported, and a Nor-
wegian study found cross-reactivity of fenugreek in pea-
nut allergic individuals. Thus, we wanted to develop a
mouse model of fenugreek allergy.
Methods
Female C3H/HeJ mice were gavaged at days 0, 1, 2, 7,
and 21 with fenugreek in doses ranging from 0.1 mg to
10 mg. Cholera toxin (CT) was used as an adjuvant (10
µg/mouse). The mice were euthanized on day 28, and
sera were analysed for fenugreek-specific IgE using the
heterologous passive cutaneous anaphylaxis assay. Based
on this dose-response experiment, twenty four mice
were gavaged with the optimal dose of fenugreek (4.2
mg) and CT at days 0, 1, 2, 7, 21 and 28. Eight mice
were gavaged with CT only and 8 mice were not treated.
At day 35 all mice received a large dose of fenugreek
(25.0 mg) and clinical reactions were observed.
Results
We found the optimal dose that would elicit the stron-
gest IgE response to be 4.24 mg fenugreek. Provocation
with fenugreek in immunised animals resulted in clinical
reactions like scratching and rubbing around the nose
and head, puffiness around the eyes and mouth as well
as laboured respiration.
Conclusion
We have established a mouse model of fenugreek allergy
to be used in further studies of primary fenugreek
allergy and in cross-reactions with other legumes.
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